Showing results (51-60 of 240) with videos related to
Sort By:
Pageof 24
Plos One|March 12, 2024
Framework-based qualitative analysis of free responses of Large Language Models: Algorithmic fidelityAliya Amirova, Theodora Fteropoulli, Nafiso Ahmed, et al.International Journal of Nursing Studies|December 6, 2012
Illness perception, self-care behaviour and quality of life of heart failure patients: a longitudinal questionnaire surveyHelen Goodman, Ashi Firouzi, Winston Banya, et al.ESC Heart Failure|August 17, 2023
Real-time pulmonary artery pressure monitoring in heart failure patients: an updated cost-effectiveness analysisMartin R Cowie, Praveen Thokala, Zenichi Ihara, et al.ESC Heart Failure|September 12, 2023
The cost-effectiveness of NT-proBNP for assessment of suspected acute heart failure in the emergency departmentRyan Walkley, A Joy Allen, Martin R Cowie, et al.JACC. Cardiovascular Imaging|February 5, 2010
Cardiac sympathetic imaging with mIBG in heart failureIgnasi Carrió, Martin R Cowie, Junichi Yamazaki, et al.Plos One|September 20, 2019
Deconstruction of central line insertion guidelines based on the positive deviance approach-Reducing gaps between guidelines and implementation: A qualitative ethnographic researchRicky Cohen, Anat Gesser-Edelsburg, Arvind Singhal, et al.Plos One|June 3, 2022
Translating a theory-based positive deviance approach into an applied tool: Mitigating barriers among health professionals (HPs) regarding infection prevention and control (IPC) guidelinesRicky Cohen, Anat Gesser-Edelsburg, Arvind Singhal, et al.European Journal of Heart Failure|April 9, 2011
Cost-effectiveness of highly purified omega-3 polyunsaturated fatty acid ethyl esters in the treatment of chronic heart failure: results of Markov modelling in a UK settingMartin R Cowie, Sandrine Cure, Florence Bianic, et al.Journal of the American College of Cardiology|August 6, 2021
Sleep Disordered Breathing and Cardiovascular Disease: JACC State-of-the-Art ReviewMartin R Cowie, Dominik Linz, Susan Redline, et al.ESC Heart Failure|January 27, 2024
Estimating the clinical and budgetary impact of using angiotensin receptor neprilysin inhibitor as first line therapy in patients with HFrEFNicklas Bergh, Krister Lindmark, Johannes Lissdaniels, et al.Pageof 24